Date published: 2025-11-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ear4 Inhibitors

Ear4, a gene predicted to enable ribonuclease activity, plays a pivotal role in cellular processes such as chemotaxis and innate immune responses within mucosal environments. Its predicted localization in the lysosome and activity in the extracellular space highlight its multifaceted functions. Additionally, the orthology to human RNASE2 and RNASE3, both members of the ribonuclease A family, suggests shared functional characteristics, emphasizing the evolutionary conservation of this gene. The ribonuclease activity of Ear4 is central to its role in cellular function. Predicted to be involved in chemotaxis, Ear4 participates in the directed movement of cells, crucial for various physiological processes such as immune responses and tissue repair. Its association with the innate immune response in mucosa further underscores its importance in defending against pathogens at mucosal surfaces. The predicted extracellular space activity suggests a potential role in influencing the microenvironment, affecting communication between cells and contributing to the regulation of extracellular components.

The inhibition of Ear4 involves a diverse array of mechanisms targeting specific cellular pathways. These mechanisms include the disruption of ribonuclease activity, modulation of chemotaxis pathways, and alterations in lysosomal function. For instance, inhibitors may target the MAPK pathway, affecting downstream cellular responses and indirectly impacting Ear4. Similarly, compounds can disrupt lysosomal acidification, influencing the subcellular localization of Ear4 and impairing its function. Chemotaxis pathways may be modulated to indirectly inhibit Ear4, altering its participation in directed cell movement. These varied approaches highlight the complexity of inhibiting Ear4, reflecting the intricate interplay of cellular processes in which it is involved. In conclusion, Ear4's significance lies in its predicted ribonuclease activity and its involvement in chemotaxis and innate immune responses within mucosal environments. The orthology to ribonuclease family members further emphasizes its evolutionary importance. Inhibition strategies target specific cellular pathways, ranging from ribonuclease disruption to modulation of chemotaxis and lysosomal functions. Understanding these mechanisms provides insights into potential strategies for influencing Ear4's activity, contributing to a deeper understanding of its role in cellular and immune functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Inhibits Ear4 by disrupting extracellular signal-regulated kinase (ERK) signaling, affecting ribonuclease activity and influencing downstream pathways associated with mucosal immune responses.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Acts as an indirect inhibitor by targeting the transforming growth factor-beta (TGF-β) receptor, modulating chemotaxis pathways linked to Ear4, and altering its participation in chemotactic responses.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

Inhibits nuclear factor-kappa B (NF-κB) activation, impacting innate immune responses in mucosa and indirectly suppressing Ear4 activity through the regulation of immune-related signaling pathways.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Disrupts lysosomal acidification, affecting the subcellular localization of Ear4 and impairing its function due to mislocalization within the lysosome.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Acts as an indirect inhibitor by targeting phosphoinositide 3-kinase (PI3K), modulating chemotaxis pathways associated with Ear4 and altering its participation in chemotactic responses.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits c-Jun N-terminal kinase (JNK), impacting innate immune responses in mucosa and indirectly suppressing Ear4 activity through the regulation of immune-related signaling pathways.

NH125

278603-08-0sc-203037
5 mg
$187.00
1
(1)

Targets nucleophosmin (NPM), indirectly inhibiting Ear4 by disrupting the nucleolar localization of key proteins involved in ribonuclease activity and affecting cellular processes related to mucosal immune responses.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$275.00
$928.00
$1543.00
14
(0)

Inhibits cysteine proteases, affecting the extracellular environment and indirectly influencing Ear4 activity through alterations in the proteolytic landscape associated with ribonuclease function.

BAY 87-2243

1227158-85-1sc-507483
5 mg
$100.00
(0)

Inhibits Ear4 by disrupting hypoxia-inducible factor 1-alpha (HIF-1α) signaling, affecting ribonuclease activity and influencing downstream pathways associated with mucosal immune responses.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Acts as an indirect inhibitor by targeting myosin light chain kinase (MLCK), modulating chemotaxis pathways associated with Ear4, and altering its participation in chemotactic responses.